Skip to main content

Feasibility and safety of the posterior retroperitoneoscopic approach in the resection of aortocaval and infrarenal paraganglioma: a single-center experience



The posterior retroperitoneoscopic approach (PRA) has been under attention as a method for resection of paraganglioma (PGL) for the past few years. However, only a few studies have explored the effectiveness and safety of the PRA for aortocaval and infrarenal PGL resection.


We designed this retrospective study to investigate the safety and effectiveness of the PRA for aortocaval and infrarenal PGL resection in a single center. We retrospectively reviewed the medical records of patients who underwent PRA for PGL resection at our medical center from January 2006 to March 2021. Eight patients were enrolled, of whom six had aortocaval PGL. We investigated the surgical outcomes of enrolled patients.


The locations of the tumors in relation to the renal vein were: suprarenal in two (25.0%) patients, at the renal vein level in three (37.5%) patients, and infrarenal in three (37.5%) patients. The mean operative time of the enrolled patients was 101.5 ± 39.1 min. The mean postoperative stay was 3.5 ± 1.5 days, and the estimated blood loss was 31.3 ± 51.4 ml. There was one minor complication (chyle leakage), and two hypotensive events occurred during the surgery. Focusing on the results of the renal vein level and infrarenal PGL resection, the mean operative time, mean postoperative stay, and estimated blood loss of the patients were 109.2 ± 41.3 min, 3.5 ± 1.8 days, and 41.7 ± 56.4 ml, respectively.


The PRA for aortocaval and infrarenal PGL resection is feasible and safe. Additional data analysis and long-term follow-up are needed in the future.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3


  1. Lam AK-Y (2017) Update on adrenal tumours in 2017 World Health Organization (WHO) of endocrine tumours. Endocr Pathol 28(3):213–227

    Article  Google Scholar 

  2. Sinclair AM, Isles CG, Brown I, Cameron H, Murray GD, Robertson JW (1987) Secondary hypertension in a blood pressure clinic. Arch Intern Med 147(7):1289–1293

    CAS  Article  Google Scholar 

  3. Anderson GH Jr, Blakeman N, Streeten D (1994) The effect of age on prevalence of secondary forms of hypertension in 4429 consecutively referred patients. J Hypertens 12(5):609–615

    Article  Google Scholar 

  4. Ariton M, Maria, Juan M, Christina S, AvRuskin M, FRCP, FAAP, FACE, Theodore W (2000) Pheochromocytoma: clinical observations from a Brooklyn tertiary hospital. Endocr Pract 6(3):249–252

  5. Omura M, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T (2004) Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens Res 27(3):193–202

    Article  Google Scholar 

  6. Timmers H, Brouwers F, Hermus A, Sweep F, Verhofstad A, Verbeek A, Pacak K, Lenders J (2008) Metastases but not cardiovascular mortality reduces life expectancy following surgical resection of apparently benign pheochromocytoma. Endocr Relat Cancer 15(4):1127–1133

    CAS  Article  Google Scholar 

  7. Khorram-Manesh A, Jansson S, Wängberg B, Nilsson O, Tisell LE, Ahlman H (2006) Mortality associated with pheochromocytoma: increased risk for additional tumors. Ann N Y Acad Sci 1073(1):444–448

    Article  Google Scholar 

  8. Brouwers FM, Eisenhofer G, Lenders J, Pacak K (2006) Emergencies caused by pheochromocytoma, neuroblastoma, or ganglioneuroma. Endocrinol Metab Clin N Am 35(4):699–724, viii

  9. Netterville JL, Jackson CG, Miller FR, Wanamaker JR, Glasscock ME (1998) Vagal paraganglioma: a review of 46 patients treated during a 20-year period. Arch Otolaryngol Head Neck Surg 124(10):1133–1140

    CAS  Article  Google Scholar 

  10. Amar L, Baudin E, Burnichon N, Sv P, Sp S, Jrm B, Bertagna X, Schlumberger M, Jeunemaitre X, Gimenez-Roqueplo A-P (2007) Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas. J Clin Endocrinol Metab 92(10):3822–3828

    CAS  Article  Google Scholar 

  11. Van Hulsteijn L, Louisse A, Havekes B, Kaptein A, Jansen J, Hes F, Smit J, Corssmit E (2013) Quality of life is decreased in patients with paragangliomas. Eur J Endocrinol 168(5):689–697

    Article  Google Scholar 

  12. Van Hulsteijn LT, Heesterman B, Jansen JC, Bayley J-P, Hes FJ, Corssmit EP, Dekkers OM (2015) No evidence for increased mortality in SDHD variant carriers compared with the general population. Eur J Hum Genet 23(12):1713–1716

    Article  Google Scholar 

  13. Stolk RF, Bakx C, Mulder J, Timmers HJ, Lenders JW (2013) Is the excess cardiovascular morbidity in pheochromocytoma related to blood pressure or to catecholamines? J Clin Endocrinol Metab 98(3):1100–1106

    CAS  Article  Google Scholar 

  14. Lee JA, Duh Q-Y (2008) Sporadic paraganglioma. World J Surg 32(5):683–687

    Article  Google Scholar 

  15. Tischler A (1998) The adrenal medulla and extra-adrenal paraganglia. Functional endocrine pathology. Endocr Pathol 25(1):49–58

    Article  Google Scholar 

  16. Nozaki T, Iida H, Morii A, Fujiuchi Y, Okumura A, Fuse H (2013) Laparoscopic resection of adrenal and extra-adrenal pheochromocytoma. J Endourol 27(7):862–868

    Article  Google Scholar 

  17. Thapar PM, Dalvi AN, Kamble RS, Vijaykumar V, Shah NS, Menon PS (2006) Laparoscopic transmesocolic excision of paraganglioma in the organ of Zuckerkandl. J Laparoendosc Adv Surg Tech 16(6):620–622

    Article  Google Scholar 

  18. Wang J, Li Y, Xiao N, Duan J, Yang N, Bao J, Li Y, Mi J (2014) Retroperitoneoscopic resection of primary paraganglioma: single-center clinical experience and literature review. J Endourol 28(11):1345–1351

    Article  Google Scholar 

  19. Hattori S, Miyajima A, Hirasawa Y, Kikuchi E, Kurihara I, Miyashita K, Shibata H, Nakagawa K, Oya M (2014) Surgical outcome of laparoscopic surgery, including laparoendoscopic single-site surgery, for retroperitoneal paraganglioma compared with adrenal pheochromocytoma. J Endourol 28(6):686–692

    Article  Google Scholar 

  20. Lang B, Fu B, OuYang J-Z, Wang B-J, Zhang G-X, Xu K, Zhang J, Wang C, Shi T-P, Zhou H-X (2008) Retrospective comparison of retroperitoneoscopic versus open adrenalectomy for pheochromocytoma. J Urol 179(1):57–60

    Article  Google Scholar 

  21. Hisano M, Vicentini FC, Srougi M (2012) Retroperitoneoscopic adrenalectomy in pheochromocytoma. Clinics 67:161–167

    Article  Google Scholar 

  22. Tobias-Machado M, Rincón FR, Tulio ML, Tristao R, Hermínio JFP, Vaz RJ, Wroclawski E (2006) Laparoscopic retroperitoneal adrenalectomy as a minimally invasive option for the treatment of adrenal tumors. Arch Esp Urol 59(1):49–54

    Article  Google Scholar 

  23. Walz MK, Alesina PF, Wenger FA, Koch JA, Neumann HP, Petersenn S, Schmid KW, Mann K (2006) Laparoscopic and retroperitoneoscopic treatment of pheochromocytomas and retroperitoneal paragangliomas: results of 161 tumors in 126 patients. World J Surg 30(5):899–908

    Article  Google Scholar 

  24. Walz MK, Peitgen K, Neumann HP, Janssen OE, Philipp T, Mann K (2002) Endoscopic treatment of solitary, bilateral, multiple, and recurrent pheochromocytomas and paragangliomas. World J Surg 26(8):1005–1012

    Article  Google Scholar 

  25. Xu W, Li H, Ji Z, Yan W, Zhang Y, Xiao H, Zhang X, Liu G (2015) Comparison of retroperitoneoscopic versus transperitoneoscopic resection of retroperitoneal paraganglioma: a control study of 74 cases at a single institution. Medicine 94(7):e538

    Article  Google Scholar 

  26. Walz MK, Iova LD, Deimel J, Neumann HP, Bausch B, Zschiedrich S, Groeben H, Alesina PF (2018) Minimally invasive surgery (MIS) in children and adolescents with pheochromocytomas and retroperitoneal paragangliomas: experiences in 42 patients. World J Surg 42(4):1024–1030

    Article  Google Scholar 

  27. Xu W, Li H, Ji Z, Yan W, Zhang Y, Zhang X, Li Q (2016) Retroperitoneal laparoscopic management of paraganglioma: a single institute experience. PLoS ONE 11(2):e0149433

    Article  Google Scholar 

  28. Zawadzka K, Więckowski K, Małczak P, Wysocki M, Major P, Pędziwiatr M, Pisarska-Adamczyk M (2021) Selective vs non-selective alpha-blockade prior to adrenalectomy for pheochromocytoma: systematic review and meta-analysis. Eur J Endocrinol 184(6):751–760

    CAS  Article  Google Scholar 

  29. Kong H, Li N, Yang X-C, Nie X-L, Tian J, Wang D-X (2021) Nonselective compared with selective α-blockade is associated with less intraoperative hypertension in patients with pheochromocytomas and paragangliomas: a retrospective cohort study with propensity score matching. Anesth Analg 132(1):140

    CAS  Article  Google Scholar 

  30. Wachtel H, Kennedy EH, Zaheer S, Bartlett EK, Fishbein L, Roses RE, Fraker DL, Cohen DL (2015) Preoperative metyrosine improves cardiovascular outcomes for patients undergoing surgery for pheochromocytoma and paraganglioma. Ann Surg Oncol 22(3):646–654

    Article  Google Scholar 

  31. Brunaud L, Boutami M, Nguyen-Thi P-L, Finnerty B, Germain A, Weryha G, Fahey TJ III, Mirallie E, Bresler L, Zarnegar R (2014) Both preoperative alpha and calcium channel blockade impact intraoperative hemodynamic stability similarly in the management of pheochromocytoma. Surgery 156(6):1410–1418

    Article  Google Scholar 

  32. Groeben H, Nottebaum B, Alesina P, Traut A, Neumann H, Walz M (2017) Perioperative α-receptor blockade in phaeochromocytoma surgery: an observational case series. Br J Anaesth 118(2):182–189

    CAS  Article  Google Scholar 

  33. Shao Y, Chen R, Shen Z-j, Teng Y, Huang P, Rui W-b, Xie X, Zhou W-l (2011) Preoperative alpha blockade for normotensive pheochromocytoma: is it necessary? J Hypertens 29(12):2429–2432

    CAS  Article  Google Scholar 

  34. Kimura N, Takekoshi K, Naruse M (2018) Risk stratification on pheochromocytoma and paraganglioma from laboratory and clinical medicine. J Clin Med 7(9):242

    CAS  Article  Google Scholar 

  35. Koh J-M, Ahn SH, Kim H, Kim B-J, Sung T-Y, Kim YH, Hong SJ, Song DE, Lee SH (2017) Validation of pathological grading systems for predicting metastatic potential in pheochromocytoma and paraganglioma. PLoS ONE 12(11):e0187398

    Article  Google Scholar 

  36. Stenman A, Zedenius J, Juhlin CC (2019) The value of histological algorithms to predict the malignancy potential of pheochromocytomas and abdominal paragangliomas—a meta-analysis and systematic review of the literature. Cancers (Basel) 11(2):225

    CAS  Article  Google Scholar 

Download references


The authors thank Ji Young Kim (Severance Hospital), Hwanju Lee (Severance Hospital), Hee Chang Yu (Severance Hospital), and Hoyoung Kim (Severance Hospital) for technical support.


This research did not receive any specific grant from any funding agency in the public, commercial, or not-for-profit sector.

Author information

Authors and Affiliations


Corresponding author

Correspondence to Sang-Wook Kang.

Ethics declarations


Drs. Soon Min Choi, Sun Hyung Choi, Hye Ryeon Choi, Jin Kyong Kim, Cho Rok Lee, Jandee Lee, Jong Ju Jeong, Kee-Hyun Nam, Woong Youn Chung, and Sang-Wook Kang have no conflicts of interest or financial ties to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file3 (MP4 717540 kb)

Supplementary file1 (DOCX 849 kb)

Supplementary file2 (DOCX 12 kb)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Choi, S.M., Choi, S.H., Choi, H.R. et al. Feasibility and safety of the posterior retroperitoneoscopic approach in the resection of aortocaval and infrarenal paraganglioma: a single-center experience. Surg Endosc 35, 7246–7252 (2021).

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI:


  • Paraganglioma
  • Posterior retroperitoneoscopic approach
  • Aortocaval paraganglioma
  • Infrarenal paraganglioma
  • Surgical outcome